CONSIDER PARTIAL EXIT KG (KING) AND ALO (ALPHARMA)

There are over 5% gains in just one day. Our methodology calls for taking partial profits in KG here at…
Read more »
 

SHORT KG ( KING PHARMACEUTICAL ), BUY ALO (ALPHARMA)

KG today made public its $33 cash offer for ALO ( Alpharma ). Normally stock of the acquirer falls, but…
Read more »

You are receiving less than 2% of the content from our paid services ...TO RECEIVE REMAINING 98%, TAKE A FREE TRIAL TO PAID SERVICES.

Please click here to take advantage of a FREE 30 day trial.

Check out our enviable performance in both bull and bear markets.

 

CAUTION AGAINST SHORTING SNDK ( SANDISK )

As our readers know, we have been very negative on SNDK and have made money shorting stock dropped $ following…
Read more »
 

PARTIAL SELL ERTS ( ELECTRONIC ARTS )

Our indicators demand trimming of ERTS position right here at $ A tight sell stop on rest of the position…
Read more »

You are receiving less than 2% of the content from our paid services ...TO RECEIVE REMAINING 98%, TAKE A FREE TRIAL TO PAID SERVICES.

Please click here to take advantage of a FREE 30 day trial.

Check out our enviable performance in both bull and bear markets.

 

SELL ANAD ( ANADIGICS )

With 17% gain in such a short period, our methodology calls for selling at least part of the position at…
Read more »
 

BUY ANAD ( ANADIGICS )

Our readers are well aware of correct calls on ANAD. We have been short. This morning's reaction is severe overreaction…
Read more »
 

BUY TO COVER AKAM ( AKAMAI )

We are short AKAM from $28. Our proprietary indicators are now flashing a BUY TO COVER signal. Cover right here…
Read more »
 

BUY TO COVER ANAD ( ANADIGICS )

On Aug 20, 2008, we starting shorting ANAD . If our methodology was followed, the average short price would have…
Read more »
 

ADD TO QCOM ( QUALCOM )

QCOM was down yesterday on its COO Sanjay Jha leaving to become co-CEO of Motorola. Contrary to market reaction, we…
Read more »
 

SHORT AKAM ( AKAMAI )

Competition has increased in AKAM's niche and likely to continue to increase. AKAM will continue to lose market earnings release,…
Read more »
Follow

Get every new post delivered to your Inbox

Join other followers